Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pelubiprofen vs Loxoprofen in Acute URI
NCT01779271Phase 3Completed
- Sponsor
- Daewon Pharm
- Start
- Jan 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pelubiprofen in acute upper respiratory infection (URI), fever, sponsored by Daewon Pharm. Started Jan 2013; status: completed.
02
Drugs
pelubiprofen
03
Conditions
acute upper respiratory infection (URI)fever
Beyond the preview
Go deeper on NCT01779271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01779271.